Physician

Gerry A Love, MD

According to 2025 Medicare claims, Gerry Love, MD (NPI: 1437157625) practices cardiology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is CENTRAL NEW YORK CARDIOLOGY, PC (NPI: 1750339412; TIN: 161225773) and primary practice location at 13502-4208. Love is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), Trinity Health Integrated Care (ACO ID: A3454), and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Love's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,935 traditional Medicare patients, billed 3,765 HCPCS/CPT codes, and received $314,066 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,496 prescription claims across 1,688 beneficiaries totaling $1,801,473 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 77 records totaling $1,055. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $290,894 to $1,801,473. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,934	4,482	$348,597
2016	2,032	4,586	$359,666
2017	2,204	5,496	$440,635
2018	2,490	4,899	$391,283
2019	2,210	5,429	$422,616
2020	1,915	4,744	$376,898
2021	1,853	3,950	$416,733
2022	1,984	4,211	$485,057
2023	1,940	4,383	$497,242
2024	1,935	3,765	$314,066

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	616	4,047	$290,894
2016	763	4,221	$455,805
2017	918	4,603	$507,940
2018	1,056	5,099	$717,716
2019	1,142	5,515	$775,089
2020	1,317	6,060	$971,182
2021	1,370	6,262	$1,108,540
2022	1,484	6,376	$1,249,089
2023	1,585	7,306	$1,638,971
2024	1,688	7,496	$1,801,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$3,404
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$584
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$714

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	526	529	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	567	617	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	183	185	$60
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	154	155	$49
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	218	236	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	601	42,069	$775,815
Entresto	Sacubitril/Valsartan	202	12,308	$260,563
Xarelto	Rivaroxaban	169	12,295	$219,888
Repatha Sureclick	Evolocumab	95	6,801	$127,125
Jardiance	Empagliflozin	90	6,011	$111,326

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$714

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	77	$1,055	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gerry A. Love, MD?

Tedicare shows public-source Medicare data for Gerry A. Love, MD (NPI 1437157625), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerry A. Love, MD have ACO affiliation data?

Gerry A. Love, MD is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612), Trinity Health Integrated Care (MSSP, ACO ID A3454), and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Gerry A. Love, MD?

Gerry A. Love, MD is linked to CENTRAL NEW YORK CARDIOLOGY, PC (billing NPI 1750339412) in the available physician profile data.

Does Gerry A. Love, MD have Open Payments data?

Gerry A. Love, MD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.